This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Context. “Compound 14” (Shionogi) is an HIV-1 protease inhibitor being developed for HIV treatment. Despite the existence of two generations…
molecule
11 months ago ●
2 mins read
Context. ”Compound 53” (University of Texas Southwestern Medical Center) is a stimulator of interferon (IFN) genes (STING) agonist. STING agonists…
molecule
11 months ago ●
3 mins read
Context. PRN1008 (rilzabrutinib, Sanofi) is an oral, reversible covalent Bruton’s tyrosine kinase (BTK) inhibitor in a Ph. III trial for…
molecule
12 months ago ●
5 mins read
Context. INE963 (Novartis Institute for Tropical Diseases) is an oral, single dose, fast-acting blood-stage antimalarial candidate. The molecule was identified…
molecule
12 months ago ●
4 mins read
Context. MK-1454 (Merck) is an intratumoral stimulator of interferon (IFN) genes (STING) agonist that is being developed for treatment of…
molecule
12 months ago ●
3 mins read
Context. “Compound 24” (Amgen) is a kinesin-like protein 18A (KIF18A) inhibitor being developed for a subset of cancers with chromosomally…
molecule
12 months ago ●
4 mins read
Load More
